欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0843/001
药品名称Letrozole Bluefish
活性成分
    • letrozole 2.5 mg
剂型Film-coated tablet
上市许可持有人Bluefish Pharmaceuticals AB, Stockholm, Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Iceland (IS)
    • Germany (DE)
      Letrozole Bluefish 2,5 mg Filmtabletten
    • Denmark (DK)
    • Ireland (IE)
    • Austria (AT)
      Letrozol Bluefish 2,5 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Letrozole Bluefish
许可日期2009/11/27
最近更新日期2023/07/27
药物ATC编码
    • L02BG04 letrozole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase